Get a glimpse into our company and investor data—powered by the PitchBook Platform
AngelLATEST DEAL TYPE
$2.75MLATEST DEAL AMOUNT
Developer of hemoglobin based technologies. The company provides intravenous oxygen-delivery support to help stabilize the patient and prevent tissue damage or organ dysfunction associated with oxygen deprivation.